Published in J Neurol on March 05, 2014
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 9.58
Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol (2006) 6.06
Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol (2010) 5.79
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2008) 5.77
Intracerebral haemorrhage. Lancet (2009) 5.15
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology (2006) 4.88
Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke (1997) 4.55
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke (2007) 3.43
Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med (2001) 3.24
Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology (2004) 3.21
Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol (2012) 2.94
Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol (2007) 2.92
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology (2004) 2.85
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke (2011) 2.81
Reversal of transtentorial herniation with hypertonic saline. Neurology (2008) 2.65
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology (2000) 2.59
Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg (2002) 2.40
Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol (1971) 2.35
Individual patient data subgroup meta-analysis of surgery for spontaneous supratentorial intracerebral hemorrhage. Stroke (2012) 2.26
Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke (1998) 2.25
Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology (1994) 2.21
The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology (2007) 2.13
Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology (2012) 2.06
Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM (2006) 2.05
Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain (2007) 2.04
Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke (1996) 2.00
Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Database Syst Rev (2008) 2.00
Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev (2013) 1.98
Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis (2006) 1.91
Progression of mass effect after intracerebral hemorrhage. Stroke (1999) 1.90
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke (2009) 1.89
Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg (1994) 1.87
Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke (2003) 1.87
Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke (2005) 1.83
Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg (1998) 1.81
Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl (2006) 1.81
Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol (2000) 1.80
Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke (1996) 1.79
Effect of blood pressure and diabetes on stroke in progression. Lancet (1994) 1.76
Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke (2004) 1.70
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke (2007) 1.68
Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J Neurol Sci (2007) 1.67
Progressing stroke: towards an internationally agreed definition. Cerebrovasc Dis (2004) 1.67
Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc (2007) 1.66
Operative intervention for delayed symptomatic radionecrotic masses developing following stereotactic radiosurgery for cerebral arteriovenous malformations--case analysis and literature review. Acta Neurochir (Wien) (2010) 1.66
Minimally invasive surgery for spontaneous supratentorial intracerebral hemorrhage: a meta-analysis of randomized controlled trials. Stroke (2012) 1.58
Postcontrast CT extravasation is associated with hematoma expansion in CTA spot negative patients. Stroke (2009) 1.58
Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke (1998) 1.58
Hyperglycemia and short-term outcome in patients with spontaneous intracerebral hemorrhage. Neurocrit Care (2008) 1.57
Emergency craniotomy in patients worsening due to expanded cerebral hematoma: to what purpose? Neurology (2002) 1.54
Natural history of perihematomal edema after intracerebral hemorrhage measured by serial magnetic resonance imaging. Stroke (2010) 1.54
Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke (1997) 1.48
Complications of intracerebral haemorrhage. Lancet Neurol (2012) 1.47
Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery (2004) 1.47
Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke (2009) 1.46
Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci (1997) 1.45
Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation (2008) 1.44
Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke (2004) 1.41
Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res (2002) 1.39
Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci (2000) 1.38
Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery (2006) 1.35
Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke (2002) 1.35
Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol (2000) 1.35
Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg (1992) 1.34
Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke (2013) 1.34
Chronological changes of perihematomal edema of human intracerebral hematoma. Acta Neurochir Suppl (2003) 1.33
Treatment of intracerebral haemorrhage. Lancet Neurol (2005) 1.31
Intraventricular hemorrhage: Anatomic relationships and clinical implications. Neurology (2008) 1.30
The spot sign in intracerebral hemorrhage: the importance of looking for contrast extravasation. Cerebrovasc Dis (2009) 1.30
Clinical applications of the computed tomography angiography spot sign in acute intracerebral hemorrhage: a review. Stroke (2012) 1.29
Defining the CT angiography 'spot sign' in primary intracerebral hemorrhage. Can J Neurol Sci (2009) 1.28
Blood-brain barrier breakdown and repair by Src after thrombin-induced injury. Ann Neurol (2010) 1.26
Delayed intraventricular hemorrhage is common and worsens outcomes in intracerebral hemorrhage. Neurology (2013) 1.24
Iron toxicity in mice with collagenase-induced intracerebral hemorrhage. J Cereb Blood Flow Metab (2010) 1.22
Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke (2004) 1.20
Chronic encapsulated intracerebral hematoma. Neurosurgery (1981) 1.20
Brain edema after human cerebral hemorrhage: a magnetic resonance imaging volumetric analysis. J Neurosurg Anesthesiol (2003) 1.19
Contrast extravasation on computed tomography angiography predicts clinical outcome in primary intracerebral hemorrhage: a prospective study of 139 cases. Stroke (2011) 1.18
Clinicopathological study on chronic encapsulated expanding hematoma associated with incompletely obliterated AVM after stereotactic radiosurgery. Acta Neurochir (Wien) (2010) 1.15
Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke (2009) 1.13
Surgery for spontaneous intracerebral hemorrhage has greater remedial value than conservative therapy. Surg Neurol (2006) 1.13
Decompressive hemicraniectomy in patients with supratentorial intracerebral hemorrhage. Stroke (2012) 1.13
Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nat Med (2011) 1.10
Thrombin-induced activation of cultured rodent microglia. J Neurochem (2000) 1.09
International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep (2012) 1.09
The epidemiology of intracerebral hemorrhage in the United States from 1979 to 2008. Neurocrit Care (2013) 1.08
Thrombin-receptor activation and thrombin-induced brain tolerance. J Cereb Blood Flow Metab (2002) 1.06
Brain edema after intracerebral hemorrhage: mechanisms, treatment options, management strategies, and operative indications. Neurosurg Focus (2007) 1.05
Peripheral leukocyte counts and outcomes after intracerebral hemorrhage. J Neuroinflammation (2011) 1.04
Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med (1987) 1.04
The relationship between statins and depression: a review of the literature. Expert Opin Pharmacother (2013) 1.45
Golgi apparatus and neurodegenerative diseases. Int J Dev Neurosci (2008) 1.16
The role of the Golgi apparatus in oxidative stress: is this organelle less significant than mitochondria? Free Radic Biol Med (2011) 0.93
Morphological alteration of Golgi apparatus and subcellular compartmentalization of TGF-beta1 in Golgi apparatus in gerbils following transient forebrain ischemia. Neurochem Res (2007) 0.86
Mechanism and Therapy of Brain Edema after Intracerebral Hemorrhage. Cerebrovasc Dis (2016) 0.84
The role of the Golgi-resident SPCA Ca²⁺/Mn²⁺ pump in ionic homeostasis and neural function. Neurochem Res (2011) 0.82
Peripheral polymorphonuclear leukocyte activation as a systemic inflammatory response in ischemic stroke. Neurol Sci (2013) 0.81
Acute dystonia induced by lamivudine. Clin Neuropharmacol (2005) 0.80
The study of Golgi apparatus in Alzheimer's disease. Neurochem Res (2007) 0.80
Blockade of Ser16-Hsp20 phosphorylation attenuates neuroprotection dependent upon Bcl-2 and Bax. Curr Neurovasc Res (2013) 0.80
HSPB2/MKBP, a novel and unique member of the small heat-shock protein family. J Neurosci Res (2008) 0.79
Giant cell arteritis: a rare disease in Asians. J Clin Rheumatol (2009) 0.79
Characterization of Golgi scaffold proteins and their roles in compartmentalizing cell signaling. J Mol Histol (2013) 0.78
Hsp20 protects neuroblastoma cells from ischemia/reperfusion injury by inhibition of apoptosis via a mechanism that involves the mitochondrial pathways. Curr Neurovasc Res (2010) 0.78
Study of GOLPH3: a potential stress-inducible protein from Golgi apparatus. Mol Neurobiol (2014) 0.77
Study of αB-crystallin expression in Gerbil BCAO model of transient global cerebral ischemia. Oxid Med Cell Longev (2012) 0.77
HSP22 and its role in human neurological disease. Curr Neurovasc Res (2011) 0.77
HspB8 expression in brain tissue after cerebral ischemic reperfusion and atorvastatin intervention in Sprague-Dawley rats. Neurol Res (2014) 0.76
Transient cerebral ischemia leads to TGF-beta2 expression in Golgi apparatus organelles. Curr Neurovasc Res (2008) 0.76
Small heat shock proteins: recent advances in neuropathy. Curr Neurovasc Res (2010) 0.76
The role of GRASPs in morphological alterations of Golgi apparatus: mechanisms and effects. Rev Neurosci (2013) 0.76
ApoE Polymorphisms and the Risk of Different Subtypes of Stroke in the Chinese Population: A Comprehensive Meta-Analysis. Cerebrovasc Dis (2016) 0.75
[Experimental research of PDE5 activity in corpora cavernosa of ganyu qizhi rat model]. Zhonghua Nan Ke Xue (2004) 0.75
Use of 31P magnetic resonance spectroscopy to study the effect of cortical magnesium and energy metabolism after subarachnoid hemorrhage. Cerebrovasc Dis (2008) 0.75
Inhibition of sphingomyelin synthase 1 affects ceramide accumulation and hydrogen peroxide-induced apoptosis in Neuro-2a cells. Neuroreport (2016) 0.75
Association of protein Z and factor VII gene polymorphisms with risk of cerebral hemorrhage: a case-control and a family-based association study in a Chinese Han population. J Genet (2016) 0.75
[Subcellular localization of ataxin-3 and its effect on the morphology of cytoplasmic organoids]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2015) 0.75
Room-temperature up-conversion random lasing from CsPbBr quantum dots with TiO nanotubes. Opt Lett (2019) 0.75
Highly pure green light emission of perovskite CsPbBr<sub>3</sub> quantum dots and their application for green light-emitting diodes. Opt Express (2016) 0.75
The study of the Golgi apparatus in blood--basic science and clinical applications. Clin Lab (2010) 0.75
The potential role of small heat shock proteins in mitochondria. Cell Signal (2013) 0.75
Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin. J Drug Target (2009) 0.75
Pre-treatment of 17β-estradiol Attenuates Cerebral-Ischemia-Induced Blood-Brain Barrier Disruption in Aged Rats: Involvement of Antioxidant Signaling. Neuroendocrinology (2017) 0.75
Chorea-ballism associated with ketotic hyperglycemia. Neurol Sci (2014) 0.75
[Polyglutamine-expanded ataxin-3 is degraded by autophagy]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2010) 0.75